{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:20:47Z","timestamp":1777929647483,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT098012"],"award-info":[{"award-number":["WT098012"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/K001418\/1"],"award-info":[{"award-number":["BB\/K001418\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.molmet.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T02:35:25Z","timestamp":1430620525000},"page":"528-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice"],"prefix":"10.1016","volume":"4","author":[{"given":"Giuseppe","family":"D'Agostino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Cristiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Citraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Avagliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina Mattace","family":"Raso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosaria","family":"Meli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lora K.","family":"Heisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Calignano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2015.04.005_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/104012371302500209","article-title":"An exploratory study examining lipid-lowering medications in reducing fasting serum lipids in schizophrenia patients treated with atypical antipsychotics","volume":"25","author":"Vincenzi","year":"2013","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1016\/j.molmet.2015.04.005_bib2","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","article-title":"Therapeutic roles of peroxisome proliferator-activated receptor agonists","volume":"54","author":"Staels","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2015.04.005_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1749-6632.1996.tb18621.x","article-title":"The peroxisome proliferator-activated receptors: ligands and activators","volume":"804","author":"Forman","year":"1996","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.molmet.2015.04.005_bib4","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1073\/pnas.91.15.7355","article-title":"Differential expression and activation of a family of murine peroxisome proliferator-activated receptors","volume":"91","author":"Kliewer","year":"1994","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.molmet.2015.04.005_bib5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.ATV.0000163844.07815.c4","article-title":"Fenofibric acid, an active form of fenofibrate, increases apolipoprotein A-I-mediated high-density lipoprotein biogenesis by enhancing transcription of ATP-binding cassette transporter A1 gene in a liver X receptor-dependent manner","volume":"25","author":"Arakawa","year":"2005","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.molmet.2015.04.005_bib6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/ATVBAHA.111.225383","article-title":"Peroxisome proliferator-activated receptor-alpha activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway","volume":"31","author":"Nakaya","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.molmet.2015.04.005_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbb.2013.08.001","article-title":"Possible beneficial effect of peroxisome proliferator-activated receptor (PPAR)-alpha and gamma agonist against a rat model of oral dyskinesia","volume":"111","author":"Grover","year":"2013","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.molmet.2015.04.005_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.biopsych.2010.04.016","article-title":"Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors","volume":"68","author":"Melis","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.molmet.2015.04.005_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/10401230490453293","article-title":"Atypical antipsychotic induced weight gain: pathophysiology and management","volume":"16","author":"Ananth","year":"2004","journal-title":"Annals of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.molmet.2015.04.005_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nutres.2010.04.002","article-title":"Alterations in lipid profile of autistic boys: a case control study","volume":"30","author":"Kim","year":"2010","journal-title":"Nutrition Research"},{"key":"10.1016\/j.molmet.2015.04.005_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng.171","article-title":"Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database","volume":"40","author":"Allen","year":"2008","journal-title":"Nature Genetics"},{"key":"10.1016\/j.molmet.2015.04.005_bib12","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.neuron.2008.09.037","article-title":"Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative\/repetitive behavior","volume":"60","author":"Hoeffer","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.molmet.2015.04.005_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature13248","article-title":"Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission","volume":"511","author":"Karayannis","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2015.04.005_bib14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nm.2125","article-title":"Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice","volume":"16","author":"Shmelkov","year":"2010","journal-title":"Nature Medicine"},{"key":"10.1016\/j.molmet.2015.04.005_bib15","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature06104","article-title":"Cortico- striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice","volume":"448","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2015.04.005_bib16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1126\/science.1148045","article-title":"Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase","volume":"318","author":"Behrens","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.molmet.2015.04.005_bib17","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1073\/pnas.91.9.4009","article-title":"Functional synergism between putative gamma-aminobutyrate-containing neurons and pyramidal neurons in prefrontal cortex","volume":"91","author":"Wilson","year":"1994","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.molmet.2015.04.005_bib18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nrn1519","article-title":"Interneurons of the neocortical inhibitory system","volume":"5","author":"Markram","year":"2004","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.molmet.2015.04.005_bib19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/ajp.154.6.805","article-title":"Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers","volume":"154","author":"Breier","year":"1997","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.molmet.2015.04.005_bib20","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1073\/pnas.0308455101","article-title":"NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex","volume":"101","author":"Jackson","year":"2004","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.molmet.2015.04.005_bib21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/mp.2011.31","article-title":"A\u00a0critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior","volume":"17","author":"Carlen","year":"2012","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.molmet.2015.04.005_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nature08002","article-title":"Driving fast-spiking cells induces gamma rhythm and controls sensory responses","volume":"459","author":"Cardin","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2015.04.005_bib23","doi-asserted-by":"crossref","first-page":"e6755","DOI":"10.1371\/journal.pone.0006755","article-title":"NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness","volume":"4","author":"Hakami","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.molmet.2015.04.005_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","article-title":"Autism-like behavioral phenotypes in BTBR T+tf\/J mice","volume":"7","author":"McFarlane","year":"2008","journal-title":"Genes Brain Behavior"},{"key":"10.1016\/j.molmet.2015.04.005_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1517\/17460441.2012.678828","article-title":"New directions in the treatment of autism spectrum disorders from animal model research","volume":"7","author":"Chadman","year":"2012","journal-title":"Expert Opinion on Drug Discovery"},{"key":"10.1016\/j.molmet.2015.04.005_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10519-011-9501-2","article-title":"Mecp2 truncation in male mice promotes affiliative social behavior","volume":"42","author":"Pearson","year":"2012","journal-title":"Behavior Genetics"},{"key":"10.1016\/j.molmet.2015.04.005_bib27","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.neuropharm.2011.01.022","article-title":"GABAergic interneuron origin of schizophrenia pathophysiology","volume":"62","author":"Nakazawa","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmet.2015.04.005_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","article-title":"Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia","volume":"35","author":"Lewis","year":"2012","journal-title":"Trends in Neuroscience"},{"key":"10.1016\/j.molmet.2015.04.005_bib29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0361-9230(01)00526-3","article-title":"Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity","volume":"55","author":"Reynolds","year":"2001","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.molmet.2015.04.005_bib30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"Lisman","year":"2008","journal-title":"Trends in Neuroscience"},{"key":"10.1016\/j.molmet.2015.04.005_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1056-4993(18)30142-1","article-title":"Research Units on Pediatric Psychopharmacology (RUPP) autism network. Background and rationale for an initial controlled study of risperidone","volume":"9","author":"McDougle","year":"2000","journal-title":"Child and Adolescent Psychiatric Clinics of North America"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.molmet.2015.04.005_bib32","first-page":"15","article-title":"Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders","volume":"69","author":"McDougle","year":"2008","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.molmet.2015.04.005_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2005.05.001","article-title":"Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan","volume":"80","author":"Huang","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.molmet.2015.04.005_bib34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1176\/appi.ajp.157.6.975","article-title":"Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study","volume":"157","author":"Henderson","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.molmet.2015.04.005_bib35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archpsyc.59.11.1021","article-title":"An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients","volume":"59","author":"Koro","year":"2002","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.molmet.2015.04.005_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0920-9964(02)00305-5","article-title":"Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol","volume":"60","author":"Atmaca","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.molmet.2015.04.005_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-003-1529-4","article-title":"Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses","volume":"170","author":"Melkersson","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.molmet.2015.04.005_bib38","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1210\/en.2005-1536","article-title":"Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: role in liver and brain","volume":"147","author":"Knauf","year":"2006","journal-title":"Endocrinology"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877815000770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877815000770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:14:54Z","timestamp":1761956094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877815000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2212877815000770"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2015.04.005","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier GmbH","name":"copyright","label":"Copyright"}]}}